Brussels, 22/08/2000 (Agence Europe) - Canada has until 7 July to amend its legislation on pharmaceutical patenting so as to stop authorising the production and storage of generic medicines during the six months that preceded the expiry of a patent. This ruling issued on Friday by an arbitrator at the World Trade Organisation confirms the ruling passed down end-March by a special group of WTO experts, convened following a complaint from the EU (see EUROPE of 24 March, p.10). The panel of...